Expanding decentralized clinical trials demands flexibility
It's important to be creative when overcoming obstacles to access to wider improvements in trial design and participation, says Jane Myles, VP of clinical trial innovation at Curebase.
Want to get more stories like this
one? Get daily news updates from Healthcare IT News.
Most Read
Research
White Papers
Compliance & Legal
Artificial Intelligence
